Document is current

Any future updates will be listed below

Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment

Crossref DOI link: https://doi.org/10.1007/s13238-017-0489-0

Published Online: 2017-11-15

Published Print: 2018-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark